Table 5 Characteristics of patients treated with RAS inhibitors or CCBs in hemodialysis patients
RAS inhibitors | (−) | (−) | (+) | (+) |
|---|---|---|---|---|
CCBs | (−) | (+) | (−) | (+) |
Number | 65 | 23 | 18 | 38 |
Age (years) | 59.9±11.6 | 63.7±11.3 | 58.7±11.9 | 61.9±11.4 |
Sex, men (%) | 66 | 56 | 61 | 61 |
Duration of dialysis (months) | 138.8±105.3 | 94.5±89.8 | 129.4±111.2 | 140.6±111.9 |
Waist circumference (cm) | 83.3±9.4 | 82.4±9.0 | 83.1±11.3 | 84.3±10.1 |
Visceral fat area (cm2) | 84.3±9.4 | 82.4±9.0 | 83.1±11.3 | 84.4±10.1 |
Subcutaneous fat area (cm2) | 90.7±45.0 | 86.3±45.8 | 105.3±52.5 | 96.9±56.9 |
Systolic BP (mm Hg) | 139.4±22.2 | 146.7±24.3 | 150.1±24.7 | 152.8±20.4 |
Diastolic BP (mm Hg) | 78.7±12.5 | 82.3±13.6 | 84.7±14.1 | 84.9±12.8 |
Pulse pressure (mm Hg) | 59.8±17.7 | 64.3±15.9 | 65.4±17.8 | 67.9±17.1 |
